Literature DB >> 12771274

Canavan's leukodystrophy is associated with defects in cochlear neurodevelopment and deafness.

Gail Ishiyama1, Ivan Lopez, Robert W Baloh, Akira Ishiyama.   

Abstract

The authors present the temporal bone histopathology of two siblings (4 months old and 6 months old at autopsy) with Canavan's disease, an autosomal recessive leukodystrophy that is variably associated with sensorineural hearing loss. The histopathology demonstrated bilateral absence of the organ of Corti throughout the apical and basal cochlea and mild secondary atrophy of the spiral ganglia neurons. The vestibular end organs and ganglia were normal. These findings implicate a role of aminoacylase II in the neurodevelopment of the organ of Corti.

Entities:  

Mesh:

Year:  2003        PMID: 12771274     DOI: 10.1212/01.wnl.0000065893.60879.d3

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Does glutaric aciduria type 1 affect hearing function?

Authors:  Dilek Demiral Özgedi K; Suna Tokgöz Yılmaz; Berrak Bilginer Gürbüz; H Serap Si Vri; Gonca Sennaroğlu
Journal:  Metab Brain Dis       Date:  2022-04-30       Impact factor: 3.655

2.  The Clinical Features and Diagnosis of Canavan's Disease: A Case Series of Iranian Patients.

Authors:  Parvaneh Karimzadeh; Narjes Jafari; Habibe Nejad Biglari; Elham Rahimian; Farzad Ahmadabadi; Hamid Nemati; Mohamad Mehdi Nasehi; Mohammad Ghofrani; Mohsen Mollamohammadi
Journal:  Iran J Child Neurol       Date:  2014

3.  A new mouse model of Canavan leukodystrophy displays hearing impairment due to central nervous system dysmyelination.

Authors:  Marina R Carpinelli; Anne K Voss; Michael G Manning; Ashwyn A Perera; Anne A Cooray; Benjamin T Kile; Rachel A Burt
Journal:  Dis Model Mech       Date:  2014-03-28       Impact factor: 5.758

4.  Loss of central auditory processing in a mouse model of Canavan disease.

Authors:  Georg von Jonquieres; Kristina E Froud; Claudia B Klugmann; Ann C Y Wong; Gary D Housley; Matthias Klugmann
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.